Iovance’s AMTAGVI receives accelerated approval from FDA
Iovance Biotherapeutics announced recently its AMTAGVI, a therapy for advanced melanoma had received U.S. Federal Drug Administration (FDA) approval for intravenous infusion. The company said AMTA...
Read More